Hematology

Acupuncture
Ambulatory Surgery Centers (ASCs)
Anesthesiology
Cardiology
Chiropractic
Dentistry
Dermatology
DME
Emergency Medicine
Endocrinology
Family Practice
Gastroenterology
General Surgery
Geriatrics
Hematology
Hepatology
Internal Medicine
Laboratory Billing
Molecular Lab
Nephrology
Neurosurgery
Nursing & Skilled Nursing
OBGYN
Oncology
Ophthalmology
Pain Management
Pathology Lab
Pediatrics
Physical Therapy
Podiatry
Primary Care
Prosthetics
Psychiatry
Psychology
Pulmonology
Radiology
Speech Therapy
TeleMedicine
Thoracic Surgery
Toxicology Lab
Home Health
Home Nursing
Immunology
Infectious Disease
Traumatology
Urology
Rheumatology
Preventive Medicine
Medical Genetics & Genomics
Addiction Medicine
Addiction Psychiatry
Otolaryngology / ENT
Plastic Surgery
Vascular Surgery
Colon & Rectal Surgery
Orthopedics / Orthopaedic Surgery
Physical Medicine & Rehab
Sports Medicine
Interventional Pain Management
Interventional Radiology
Radiation Oncology
Occupational Therapy
Audiology
Hematology
In Hematology, Drug Billing Precision Determines Profitability.

The Hematology Revenue Reality

Hematology is clinically complex and reimbursement-intensive. Small billing inaccuracies can lead to substantial financial impact.

  • J-code underpayment
  • Incorrect drug unit reporting
  • Infusion time miscalculation
  • Medical necessity denials
  • Diagnosis-to-drug mismatch
  • Prior authorization gaps
  • Wastage (JW/JZ modifier) errors
  • High-dollar AR tied to specialty medications

Drug & Infusion Coding Precision (CCP)

  • J-code accuracy and unit calculation
  • Infusion and hydration time documentation
  • JW/JZ modifier application
  • Add-on infusion code integrity
  • Diagnosis alignment for medical necessity

Target Outcome: Reduced drug-related denials and improved first-pass acceptance.

Pre-Treatment Authorization & Coverage Controls (FIO + EAE)

  • Prior authorization validation
  • Coverage confirmation for specialty medications
  • Diagnosis-to-therapy alignment
  • Frequency and benefit checks

Target Outcome: Fewer infusion and drug reimbursement rejections.

High-Dollar AR Optimization (AAF)

  • Smart triage of infusion-related claims
  • Payer-specific appeal workflows
  • Escalation ladder for drug denials
  • AR > 90 monitoring by J-code category

Target Outcome: Faster recovery of high-cost treatment revenue.

Drug-Level Reimbursement Intelligence (PRL)

  • Underpayment trends by J-code
  • Denial clustering by drug category
  • Reimbursement variance by payer
  • Appeal overturn rates on high-cost therapies

Target Outcome: Visibility into recurring infusion-related revenue leakage.

Measurable Performance Targets

  • 8–18% lift in net collections
  • 15–30% reduction in drug-related denials
  • 25–40% reduction in AR > 90
  • 95–98% first-pass claim acceptance
  • Faster appeal resolution for high-cost therapies

Compliance & Infrastructure

  • HIPAA-compliant workflows with BAA signed prior to PHI exchange
  • Integration with major EHR platforms including Epic, Cerner, Athenahealth, NextGen, eClinicalWorks and others
  • Cybersecurity oversight via Redfort Technologies
  • U.S.-based nationwide operations

Are Your High-Cost Drug Claims Being Underpaid or Denied Due to Unit Errors?

Schedule a specialized Hematology Revenue Audit and identify how coding accuracy, documentation gaps, and denial patterns are affecting your claims, AR performance, and net collections.

Schedule a FREE Audit Now